Concurrent targeted next generation sequencing looking for myeloid neoplasm associated gene aberrations detected three different alterations: a NF1 I679fs insertion mutation (allele variant frequency 17%), a JAK2 I670V point mutation (allele variant frequency 44%), and a TP53 point mutation (allele variant frequency 58%). This evidence concerns the gene JAK2 and myeloid neoplasm.